Publications by authors named "Xiaopeng Peng"

Claim this Profile
D
Discovery of novel quinazoline analogs as tubulin inhibitors targeting the colchicine binding site for potent antitumor therapy in combination with PD-L1 inhibitors.
Yichang Ren, Songwen Zhou, Chenglong Xu, Jiamin Tan, Xixiang Yang, Xiaopeng Peng

Bioorg Chem· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and bioevaluation of novel hydrazide derivatives as enhancers of immunotherapy and DNA-damage response in antitumor therapy.
Zhihao Hu, Shuqing Li, Wanyi Pan, Haiyan Wu, Xiaopeng Peng

Eur J Med Chem· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decavanadate-Catalyzed Oxidative Cross-Dehydrogenative Coupling: an Efficient and Sustainable Approach toward P(O)─S Bond Formation.
Jian Lei, Zhenliang Yu, Shi Ru, Zixiu Wang, Shan Li, Xiaopeng Peng

Angew Chem Int Ed Engl· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to "Small-Molecule Modulators Targeting Coactivator-Associated Arginine Methyltransferase 1 (CARM1) as Therapeutic Agents for Cancer Treatment: Current Medicinal Chemistry Insights and Emerging Opportunities".
Shuqing Li, Wanyi Pan, Chengpeng Tao, Zhihao Hu, Binbin Cheng, Xiaopeng Peng

J Med Chem· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: RUN-BANG ZHOU, KAI-ZHENG CHEN, QIAO-MIN LIU, XING-JUN LI, XV-MING QI, JIA-LING LI & XIAO-PENG PENG (2025) Description of a new species of the subgenus Japonigekko (Squamata: Gekkonidae: Gekko) from Hainan, China. Zootaxa, 5633 (3): 528540.
Runbang Zhou, Kaizheng Chen, Qiaomin Liu, Xingjun Li, Xvming Qi, Xiaopeng Peng

Zootaxa· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Identification and Quantification of the Positional Isomers of Dimethylbipyridine by Ion Mobility Mass Spectrometry Analysis of Their Gas Phase Complexes.
Xiaopeng Peng, Jianglong Du, Long Chen, Keqi Ye, Jiacheng Ye

Rapid Commun Mass Spectrom· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Description of a new species of the subgenus Japonigekko (Squamata: Gekkonidae: Gekko) from Hainan, China.
Run-Bang Zhou, Kai-Zheng Chen, Qiao-Min Liu, Xing-Jun Li, Xv-Ming Qi, Xiao-Peng Peng

Zootaxa· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research progress in DNA damage response (DDR)-targeting modulators: From hits to clinical candidates.
Binbin Cheng, Zongbao Ding, Yimeng Hong, Yaping Wang, Yingxing Zhou, Xiaopeng Peng

Eur J Med Chem· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Dual PD-L1/HDAC3 Inhibitors for Tumor Immunotherapy.
Zhijie Wang, HaiQi He, Xiaotong Liao, Lin Yuan, Shuding Sun, Xiaopeng Peng

J Med Chem· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small-Molecule Modulators Targeting Coactivator-Associated Arginine Methyltransferase 1 (CARM1) as Therapeutic Agents for Cancer Treatment: Current Medicinal Chemistry Insights and Emerging Opportunities.
Shuqing Li, Wanyi Pan, Chengpeng Tao, Zhihao Hu, Binbin Cheng, Xiaopeng Peng

J Med Chem· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of the epigenetic/cytotoxic dual-target inhibitors for cancer therapy.
Hailiu Liang, Shuqing Li, Xiaopeng Peng, Hao Xiao

Eur J Med Chem· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Novel and Highly Potent Dual PD-L1/Histone Deacetylase 6 Inhibitors with Favorable Pharmacokinetics for Cancer Immunotherapy.
Zhihao Hu, Shuqing Li, Haiqi He, Wanyi Pan, Ting Liu, Chengpeng Tao, Xiaopeng Peng

J Med Chem· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advances in developing targeted protein degraders.
Binbin Cheng, Hongqiao Li, Xiaopeng Peng, Jianjun Chen, Chuxiao Shao

Eur J Med Chem· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Novel Hydrazide-Based HDAC3 Inhibitors as Epigenetic Immunomodulators for Cancer Immunotherapy.
Zhiqiang Sun, Jinmei Cheng, Chenglong Xu, Xuewen Zhang, Qinru Zang, Xiaopeng Peng

J Med Chem· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Highly Potent and Orally Bioavailable Histone Deacetylase 3 Inhibitors as Immunomodulators and Enhancers of DNA-Damage Response in Cancer Therapy.
Shuqing Li, Zhihao Hu, Wanyi Pan, Haiyan Wu, Weijie Peng, Xiaopeng Peng

J Med Chem· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calcium-dependent adhesion protein CDH18, a potential biomarker for prognosis in uterine corpus endometrial carcinoma.
Xiaoxuan Tang, Shanxing Dang, Jie Qiu, Ruilan Zhou, Jing Ling, Xiaopeng Peng

Front Mol Biosci· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel thiophene[3,2-d]pyrimidine-based tubulin inhibitors with enhanced antitumor efficacy for combined use with anti-pd-l1 immunotherapy in melanoma.
Chenglong Xu, Chengyong Wu, Ling Li, Huiting Zhao, Jin Liu, Xiaopeng Peng

Eur J Med Chem· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to "Discovery of Novel Histone Deacetylase 6 (HDAC6) Inhibitors with Enhanced Antitumor Immunity of Anti-PD-L1 Immunotherapy in Melanoma".
Xiaopeng Peng, Ling Li, Jingxuan Chen, Yichang Ren, Jin Liu

J Med Chem· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent progress in the development of hypoxia-inducible factor 2α (HIF-2α) modulators: Inhibitors, agonists, and degraders (2009-2024).
Binbin Cheng, Xianshi Ma, Yingxing Zhou, Jin Liu, Xiaoting Fei, Xiaopeng Peng

Eur J Med Chem· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Discovery of novel Quinazoline-based KRAS G12C inhibitors as potential anticancer agents" [Bioorg. Med. Chem. 71 (2022) 116962].
Ling Li, Huiting Zhao, Xiaopeng Peng, Jin Liu, Ruiyao Mai

Bioorg Med Chem· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to "Discovery of Novel Acridane-Based Tubulin Polymerization Inhibitors with Anticancer and Potential Immunomodulatory Effects".
Xiaopeng Peng, Yichang Ren, Wanyi Pan, Jin Liu, Jianjun Chen

J Med Chem· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Novel HDAC3 Inhibitors with PD-L1 Downregulating/Degrading and Antitumor Immune Effects.
Zhiqiang Sun, Chenglong Xu, Jinmei Cheng, Zichao Yang, Ting Liu, Xiaopeng Peng

J Med Chem· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to "Copper-Catalyzed Selective Arylation of Nitriles with Cyclic Diaryl Iodonium Salts: Direct Access to Structurally Diversified Diarylmethane Amides with Potential Neuroprotective and Anticancer Activities".
Xiaopeng Peng, Zhiqiang Sun, Peihua Kuang, Ling Li, Jingxuan Chen

Org Lett· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent Progress in DNA Damage Response-Targeting PROTAC Degraders.
Binbin Cheng, Xiaoting Fei, Zongbao Ding, Xiaopeng Peng, Zhenhong Su

J Med Chem· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of epigenetic degraders based on PROTAC, molecular glue, and hydrophobic tagging technologies.
Xiaopeng Peng, Zhihao Hu, Limei Zeng, Meizhu Zhang, Congcong Xu, Chengpeng Tao

Acta Pharm Sin B· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis